{
    "nctId": "NCT06340230",
    "briefTitle": "SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER Positive/HER2 Low Breast Cancer",
    "officialTitle": "A Phase II Study of SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER Positive/HER2 Low Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "ER Positive/HER2 Low Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 93,
    "primaryOutcomeMeasure": "Total pathological complete response (tpCR: ypT0-is/ypN0)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients aged \u2265 18 but \u2264 75 years\n2. Histologically confirmed to be ER+/HER2-Low invasive breast cancer\n3. Treatment-naive patients with stage II-III\n4. Eastern Cooperative Oncology Group (ECOG) score is 0 or 1\n5. Good level of organ function\n6. Subjects must participate voluntarily, sign the informed consent form, have good compliance, and cooperate with follow-up visits\n\nExclusion Criteria:\n\n1. Previously been treated with any anti-tumor therapy (chemotherapy, radiotherapy, molecular targeted therapy, endocrine therapy, etc.)\n2. Received any other anti-tumor therapy at the same time\n3. Bilateral breast cancer, inflammatory breast cancer or occult breast cancer\n4. Stage IV breast cancer\n5. Not confirmed by histopathology\n6. With a history of any malignancies in the past 5 years, excluding cured cervical carcinoma in situ and melanoma skin cancer\n7. Participated in other drug clinical trials within 4 weeks before enrollment\n8. Known allergic history of the drug components of this protocol\n9. History of immunodeficiency\n10. Clinically significant cardiovascular diseases\n11. Known or suspected interstitial lung disease\n12. Active hepatitis and liver cirrhosis\n13. Known hereditary or acquired bleeding thrombotic tendency\n14. History of neurological or psychiatric disorders",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}